Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Resistance testing comes of age.

Project Inform perspective - 1 Mar 2000

Abstract excerpt

The Antiviral Drugs Advisory Committee (ADAC) to the Food and Drug Administration (FDA) recently held a two-day meeting to discuss HIV drug resistance testing. The discussion centered on currently available results from drug resistance tests and not on any one specific test or drug. For more information on HIV drug resistance and resistance testing, call Project Inform's Hotline and ask for the Geno- & Phenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Resistance, Viral
Share to Genotype
Share to HIV

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to United States

Share to United States Food and Drug Administration

Source

Identifiers

PMID: 12772663

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Resistance testing comes of age.PMID 12772663Read ↗

HIV drug resistance testing: an update for the clinician.Semantic proximity Read ↗

HIV drug resistance and you. The limitations of drug resistance testing. Many factors influence the results.Semantic proximity Read ↗

HIV drug resistance testing.Semantic proximity Read ↗

HIV drug resistance and you. Using resistance testing in clinical practice. U.S. guidelines, cost, limitations--and usefulness.Semantic proximity Read ↗

Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.Semantic proximity Read ↗

HIV resistance testing. A clinical tool.Semantic proximity Read ↗

An introduction to HIV drug resistance testing.Semantic proximity Read ↗

HIV resistance testing: methods, utility, and limitations.Semantic proximity Read ↗

Resistance assay update.Semantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.Semantic proximity Read ↗

HIV drug resistance and you. Resistance overview. A look at the basics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.